InvestorsHub Logo
Followers 4
Posts 1195
Boards Moderated 0
Alias Born 10/03/2015

Re: NY1972 post# 353

Wednesday, 09/28/2016 10:59:19 AM

Wednesday, September 28, 2016 10:59:19 AM

Post# of 977
Takeaway from CEO talk:

1. It is going to take a fluke for a microcap to beat Stanford, CELG, Roche ...

2. Targeting the biggest fish to fry(anti PD1) with P1 IT solid tumors

3. A few PRs and no anemia in P1a as TTI622 or Rituximab combo not on radar